Maintenance treatment of patients w/ COPD (including chronic bronchitis & emphysema); associated dyspnoea, the improvement of COPD compromised quality of life & reduction of exacerbations. Spiriva Respimat As add-on maintenance treatment for the improvement of asthma symptoms, quality of life & reduction of exacerbations in patients ≥6 yr w/ asthma who remain symptomatic on at least inhaled corticosteroids.
Spiriva 1 cap inhaled once daily via Handihaler (1 puff once daily at the same time of day). Spiriva Respimat 2 puff once daily at the same time of day.
Immediate hypersensitivity reactions may occur. Not for initial treatment of acute episodes of bronchospasm or for relief of acute symptoms. Patients w/ narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction. May cause inhalation-induced bronchospasm. Not to be used more frequently than once daily. Occurrence of dizziness or blurred vision may influence the ability to drive & use machinery. Moderate to severe renal impairment (CrCl ≤50 mL/min). Avoid use during pregnancy. Lactation. Spiriva Avoid the powd to enter from entering the eyes. Contains lactose monohydrate. Infants & childn. Spiriva Respimat Not to be used as 1st-line treatment of asthma; use more frequently than once daily. Avoid the soln or mist from entering the eyes. Contains benzalkonium Cl which may cause wheezing & breathing difficulties especially in patients w/ asthma. Childn <1 yr w/ asthma.
Sign Out
